On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Schlumberger Limited SLB is the No.1 company in the industry. The stock is down 17% from its high and trades at 16 times earnings. "I like the margin story and pricing power," she added.
Susquehanna analyst Charles Minervino recently reiterated SLB with a Positive and maintained a $68 price target.
Analysts have a consensus Buy rating on SLB, according to Benzinga's analyst ratings data.
Bill Baruch of Blue Line Capital named Micron Technology, Inc. MU as his final trade.
Micron shares are trading lower following a report suggesting China's cyberspace regulator will implement a cybersecurity review on Micron's products in China.
Don’t forget to check out our premarket coverage here
Josh Brown of Ritholtz Wealth Management said oil stocks are trying to bottom here and iShares U.S. Oil & Gas Exploration & Production ETF IEO is the way to invest in this space.
Jim Lebenthal of Cerity Partners said CVS Health Corporation CVS is bottoming.
B of A Securities analyst Michael Cherny maintained CVS Health with a Buy and lowered the price target from $111 to $104.
Price Action: CVS Health shares were down 0.2% to close at $74.55, while Micron was lower by 3% at $61.20 and Schlumberger shares were up 0.53% to $49.00 at the time of publication on Friday.
Check This Out: Top 5 Health Care Stocks That May Collapse
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.